Nucleus Biologics, The Cell Performance Company™, a top provider of custom cell culture media and buffers for the cell and gene therapy sector, is excited to introduce its new QuickStart…
According to a new quarterly revenue cycle benchmarking report from Kodiak Solutions, health insurers are increasingly using requests for additional information to initially deny claims from hospitals, health systems, and…
Phonak, a Sonova brand, is excited to introduce the new Infinio hearing aid portfolio, featuring the groundbreaking Audéo Sphere Infinio. This hearing aid is the world’s first to use a…
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotech firm focused on developing small molecule drugs for virology and immunology, has reported its financial results for the fiscal third quarter ending June…
Tris Pharma, Inc., a biopharmaceutical company specializing in ADHD, pain, addiction, and neurological disorders, has announced new clinical data showcasing that cebranopadol, a dual nociceptin/orphanin FQ peptide (NOP) receptor and…
DocGo Inc. (Nasdaq: DCGO), a leader in technology-enabled mobile health services, has announced that its subsidiary, Exceptional Medical Transportation, has been granted a one-year, $4 million contract extension. This extension…
BostonGene, a leader in AI-driven molecular and immune profiling solutions, has announced a new research collaboration with Takeda focused on immuno-oncology. This partnership aims to enhance clinical solutions and patient…
Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a frontrunner in AI-driven cardiovascular medicine, has unveiled its newly redesigned website, CDIO.AI. This upgraded platform underscores the Company’s commitment to an AI-first approach…
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has announced the successful closing of its underwritten public offering, which included common stock, pre-funded warrants, and Series F-1, F-2, and F-3 warrants, raising…
HCA Healthcare, Inc. (NYSE: HCA) reported its financial and operational results for Q2 2024, ending June 30, 2024. Here are the key highlights: Second Quarter Highlights: Six-Month Summary: Balance Sheet…
CVS Caremark®, the top pharmacy benefit manager and a division of CVS Health® (NYSE: CVS), has announced a new commitment to enhance pharmacy benefits for American businesses, unions, and health…
Geron Corporation (Nasdaq: GERN) has announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include RYTELO™ (imetelstat) as a recommended treatment for symptomatic anemia…
